{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T22:48:17Z","timestamp":1778366897010,"version":"3.51.4"},"reference-count":90,"publisher":"Elsevier","isbn-type":[{"value":"9780443313585","type":"print"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK123233"],"award-info":[{"award-number":["R01DK123233"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK132038"],"award-info":[{"award-number":["R01DK132038"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["2 P30 DK097948"],"award-info":[{"award-number":["2 P30 DK097948"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007028","name":"Leona M. and Harry B. Helmsley Charitable Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007028","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/bs.apha.2024.10.012","type":"book-chapter","created":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T07:22:20Z","timestamp":1730272940000},"page":"85-106","source":"Crossref","is-referenced-by-count":1,"title":["Anti-fibrotics in inflammatory bowel diseases: Challenges and successes"],"prefix":"10.1016","member":"78","reference":[{"issue":"5","key":"10.1016\/bs.apha.2024.10.012_bib1","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1002\/ibd.21801","article-title":"Computed tomography enterography findings correlate with tissue inflammation, not fibrosis in resected small bowel Crohn\u2019s disease","volume":"18","author":"Adler","year":"2012","journal-title":"Inflammatory Bowel Diseases"},{"issue":"6","key":"10.1016\/bs.apha.2024.10.012_bib2","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1136\/gutjnl-2018-318081","article-title":"Assessment of Crohn\u2019s disease-associated small bowel strictures and fibrosis on cross-sectional imaging: A systematic review","volume":"68","author":"Bettenworth","year":"2019","journal-title":"Gut"},{"issue":"1","key":"10.1016\/bs.apha.2024.10.012_bib3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1755-1536-6-13","article-title":"The role of interleukin 17 in Crohn\u2019s disease-associated intestinal fibrosis","volume":"6","author":"Biancheri","year":"2013","journal-title":"Fibrogenesis Tissue Repair"},{"issue":"12","key":"10.1016\/bs.apha.2024.10.012_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/biom9120780","article-title":"Role of obesity, mesenteric adipose tissue, and adipokines in inflammatory bowel diseases","volume":"9","author":"Bilski","year":"2019","journal-title":"Biomolecules"},{"issue":"2","key":"10.1016\/bs.apha.2024.10.012_bib5","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.celrep.2018.03.067","article-title":"FOXF1 inhibits pulmonary fibrosis by preventing CDH2-CDH11 cadherin switch in myofibroblasts","volume":"23","author":"Black","year":"2018","journal-title":"Cell Reports"},{"issue":"2","key":"10.1016\/bs.apha.2024.10.012_bib6","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/(SICI)1096-9896(200002)190:2<196::AID-PATH513>3.0.CO;2-5","article-title":"The relationship between inflammatory and serosal connective tissue changes in ileal Crohn\u2019s disease: Evidence for a possible causative link","volume":"190","author":"Borley","year":"2000","journal-title":"The Journal of Pathology"},{"key":"10.1016\/bs.apha.2024.10.012_bib7","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.3389\/fimmu.2019.01162","article-title":"Interleukin-36 in infectious and inflammatory skin diseases","volume":"10","author":"Buhl","year":"2019","journal-title":"Frontiers in Immunology"},{"issue":"3","key":"10.1016\/bs.apha.2024.10.012_bib8","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1148\/radiol.2015150566","article-title":"Evaluation of quantitative PET\/MR enterography biomarkers for discrimination of inflammatory strictures from fibrotic strictures in Crohn disease","volume":"278","author":"Catalano","year":"2016","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/bs.apha.2024.10.012_bib9","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/ecco-jcc\/jjw126","article-title":"Smooth muscle hyperplasia\/hypertrophy is the most prominent histological change in Crohn\u2019s fibrostenosing bowel strictures: A semiquantitative analysis by using a novel histological grading scheme","volume":"11","author":"Chen","year":"2017","journal-title":"Journal of Crohn\u2019s and Colitis"},{"issue":"11","key":"10.1016\/bs.apha.2024.10.012_bib10","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1111\/j.1572-0241.2007.01537.x","article-title":"Correlation of CT enteroclysis with surgical pathology in Crohn\u2019s disease","volume":"102","author":"Chiorean","year":"2007","journal-title":"The American Journal of Gastroenterology"},{"issue":"8","key":"10.1016\/bs.apha.2024.10.012_bib11","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1136\/gutjnl-2011-301971","article-title":"Factors affecting outcomes in Crohn\u2019s disease over 15 years","volume":"61","author":"Cosnes","year":"2012","journal-title":"Gut"},{"issue":"3","key":"10.1016\/bs.apha.2024.10.012_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/cells9030775","article-title":"Pirfenidone inhibits cell proliferation and collagen I production of primary human intestinal fibroblasts","volume":"9","author":"Cui","year":"2020","journal-title":"Cells"},{"key":"10.1016\/bs.apha.2024.10.012_bib13","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3389\/fmed.2017.00126","article-title":"The role of cytokines in the fibrotic responses in Crohn\u2019s disease","volume":"4","author":"Curciarello","year":"2017","journal-title":"Frontiers in Medicine (Lausanne)"},{"key":"10.1016\/bs.apha.2024.10.012_bib14","doi-asserted-by":"crossref","first-page":"14361","DOI":"10.1038\/ncomms14361","article-title":"The molecular basis of endothelial cell plasticity","volume":"8","author":"Dejana","year":"2017","journal-title":"Nature Communications"},{"issue":"1","key":"10.1016\/bs.apha.2024.10.012_bib15","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00000658-199901000-00009","article-title":"Transforming growth factor-betas and their signaling receptors are coexpressed in Crohn\u2019s disease","volume":"229","author":"Di Mola","year":"1999","journal-title":"Annals of Surgery"},{"issue":"6","key":"10.1016\/bs.apha.2024.10.012_bib16","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/gut.2008.149096","article-title":"Transforming growth factor beta signalling and matrix metalloproteinases in the mucosa overlying Crohn\u2019s disease strictures","volume":"58","author":"Di Sabatino","year":"2009","journal-title":"Gut"},{"issue":"26","key":"10.1016\/bs.apha.2024.10.012_bib17","doi-asserted-by":"crossref","first-page":"12215","DOI":"10.1073\/pnas.92.26.12215","article-title":"Early-onset multifocal inflammation in the transforming growth factor beta 1-null mouse is lymphocyte mediated","volume":"92","author":"Diebold","year":"1995","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"10.1016\/bs.apha.2024.10.012_bib18","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1038\/s41467-018-03782-z","article-title":"STAG2 deficiency induces interferon responses via cGAS-STING pathway and restricts virus infection","volume":"9","author":"Ding","year":"2018","journal-title":"Nature Communications"},{"key":"10.1016\/bs.apha.2024.10.012_bib19","series-title":"The RAND\/UCLA appropriateness method user\u2019s manual","author":"Fitch","year":"2001"},{"issue":"3","key":"10.1016\/bs.apha.2024.10.012_bib20","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/ecco-jcc\/jjz147","article-title":"Cadherin-11 is a regulator of intestinal fibrosis","volume":"14","author":"Franze","year":"2020","journal-title":"Journal of Crohn\u2019s and Colitis"},{"issue":"4","key":"10.1016\/bs.apha.2024.10.012_bib21","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.immuni.2019.03.017","article-title":"Cytokine networks in the pathophysiology of inflammatory bowel disease","volume":"50","author":"Friedrich","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/bs.apha.2024.10.012_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2020.109661","article-title":"Fibrin fragment E potentiates TGF-beta-induced myofibroblast activation and recruitment","volume":"72","author":"Fuchs","year":"2020","journal-title":"Cellular Signalling"},{"issue":"7","key":"10.1016\/bs.apha.2024.10.012_bib23","doi-asserted-by":"crossref","first-page":"760","DOI":"10.2174\/1389450122999210120205607","article-title":"TL1A: A new potential target in the treatment of inflammatory bowel disease","volume":"22","author":"Furfaro","year":"2021","journal-title":"Current Drug Targets"},{"issue":"5","key":"10.1016\/bs.apha.2024.10.012_bib24","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1093\/ecco-jcc\/jjab216","article-title":"Paediatric ulcerative colitis is a fibrotic disease and is linked with chronicity of inflammation","volume":"16","author":"Gordon","year":"2022","journal-title":"Journal of Crohn\u2019s and Colitis"},{"issue":"7","key":"10.1016\/bs.apha.2024.10.012_bib25","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/apt.14526","article-title":"Fibrosis in ulcerative colitis is directly linked to severity and chronicity of mucosal inflammation","volume":"47","author":"Gordon","year":"2018","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"2","key":"10.1016\/bs.apha.2024.10.012_bib26","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s10620-017-4710-z","article-title":"NF-E2-related factor 2 suppresses intestinal fibrosis by inhibiting reactive oxygen species-dependent TGF-beta1\/SMADs pathway","volume":"63","author":"Guan","year":"2018","journal-title":"Digestive Diseases and Sciences"},{"issue":"12","key":"10.1016\/bs.apha.2024.10.012_bib27","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/0895-4356(92)90194-R","article-title":"Measuring health status: What are the necessary measurement properties?","volume":"45","author":"Guyatt","year":"1992","journal-title":"Journal of Clinical Epidemiology"},{"issue":"3","key":"10.1016\/bs.apha.2024.10.012_bib28","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/ibd\/izab193","article-title":"Antitumor necrosis factor-like ligand 1A therapy targets tissue inflammation and fibrosis pathways and reduces gut pathobionts in ulcerative colitis","volume":"28","author":"Hassan-Zahraee","year":"2022","journal-title":"Inflammatory Bowel Diseases"},{"issue":"1-2","key":"10.1016\/bs.apha.2024.10.012_bib29","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000449080","article-title":"Measurement of fibrosis in Crohn\u2019s disease strictures with imaging and blood biomarkers to inform clinical decisions","volume":"35","author":"Higgins","year":"2017","journal-title":"Digestive Diseases (Basel, Switzerland)"},{"issue":"12","key":"10.1016\/bs.apha.2024.10.012_bib30","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1136\/gutjnl-2011-301668","article-title":"Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn\u2019s disease: Unexpected results of a randomised, double-blind placebo-controlled trial","volume":"61","author":"Hueber","year":"2012","journal-title":"Gut"},{"issue":"6","key":"10.1016\/bs.apha.2024.10.012_bib31","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1093\/ibd\/izy062","article-title":"Knockdown of Smad7 with a specific antisense oligonucleotide attenuates colitis and colitis-driven colonic fibrosis in mice","volume":"24","author":"Izzo","year":"2018","journal-title":"Inflammatory Bowel Diseases"},{"issue":"1","key":"10.1016\/bs.apha.2024.10.012_bib32","doi-asserted-by":"crossref","first-page":"18189","DOI":"10.1038\/s41598-020-75168-5","article-title":"Direct signaling of TL1A-DR3 on fibroblasts induces intestinal fibrosis in vivo","volume":"10","author":"Jacob","year":"2020","journal-title":"Scientific Reports"},{"issue":"12","key":"10.1016\/bs.apha.2024.10.012_bib33","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.3109\/00365521.2011.613947","article-title":"Diagnostic accuracies of MR enterography and CT enterography in symptomatic Crohn\u2019s disease","volume":"46","author":"Jensen","year":"2011","journal-title":"Scandinavian Journal of Gastroenterology"},{"issue":"6","key":"10.1016\/bs.apha.2024.10.012_bib34","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1172\/JCI39104","article-title":"The basics of epithelial-mesenchymal transition","volume":"119","author":"Kalluri","year":"2009","journal-title":"The Journal of Clinical Investigation"},{"issue":"6","key":"10.1016\/bs.apha.2024.10.012_bib35","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1080\/1744666X.2022.2074401","article-title":"TL1A as a therapeutic target in inflammatory bowel disease","volume":"18","author":"Kokkotis","year":"2022","journal-title":"Expert Review of Clinical Immunology"},{"key":"10.1016\/bs.apha.2024.10.012_bib36","doi-asserted-by":"crossref","first-page":"1163198","DOI":"10.3389\/fimmu.2023.1163198","article-title":"Interleukin 36 receptor-inducible matrix metalloproteinase 13 mediates intestinal fibrosis","volume":"14","author":"Koop","year":"2023","journal-title":"Frontiers in Immunology"},{"issue":"4","key":"10.1016\/bs.apha.2024.10.012_bib37","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/S0002-9440(10)63488-8","article-title":"Thy-1 expression in human fibroblast subsets defines myofibroblastic or lipofibroblastic phenotypes","volume":"163","author":"Koumas","year":"2003","journal-title":"The American Journal of Pathology"},{"issue":"3","key":"10.1016\/bs.apha.2024.10.012_bib38","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/nrm3758","article-title":"Molecular mechanisms of epithelial-mesenchymal transition","volume":"15","author":"Lamouille","year":"2014","journal-title":"Nature Reviews. Molecular Cell Biology"},{"issue":"1","key":"10.1016\/bs.apha.2024.10.012_bib39","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3109\/00365521.2014.968863","article-title":"Mechanisms of initiation and progression of intestinal fibrosis in IBD","volume":"50","author":"Latella","year":"2015","journal-title":"Scandinavian Journal of Gastroenterology"},{"issue":"6","key":"10.1016\/bs.apha.2024.10.012_bib40","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1093\/ibd\/izaa015","article-title":"Endoplasmic reticulum stress in subepithelial myofibroblasts increases the TGF-beta1 activity that regulates fibrosis in Crohn\u2019s disease","volume":"26","author":"Li","year":"2020","journal-title":"Inflammatory Bowel Diseases"},{"issue":"2","key":"10.1016\/bs.apha.2024.10.012_bib41","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.prp.2017.11.017","article-title":"TL1A blocking ameliorates intestinal fibrosis in the T cell transfer model of chronic colitis in mice","volume":"214","author":"Li","year":"2018","journal-title":"Pathology, Research and Practice"},{"issue":"7","key":"10.1016\/bs.apha.2024.10.012_bib42","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1007\/s10620-019-05969-w","article-title":"Role of interleukin-17 in pathogenesis of intestinal fibrosis in mice","volume":"65","author":"Li","year":"2020","journal-title":"Digestive Diseases and Sciences"},{"key":"10.1016\/bs.apha.2024.10.012_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.trsl.2019.03.005","article-title":"Pathogenesis of fibrostenosing Crohn\u2019s disease","author":"Li","year":"2019","journal-title":"Translational Research: The Journal of Laboratory and Clinical Medicine"},{"issue":"2","key":"10.1016\/bs.apha.2024.10.012_bib44","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1152\/physrev.00005.2021","article-title":"Development of antifibrotic therapy for stricturing Crohn\u2019s disease: Lessons from randomized trials in other fibrotic diseases","volume":"102","author":"Lin","year":"2022","journal-title":"Physiological Reviews"},{"issue":"6","key":"10.1016\/bs.apha.2024.10.012_bib45","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/gut.49.6.777","article-title":"Behaviour of Crohn\u2019s disease according to the Vienna classification: Changing pattern over the course of the disease","volume":"49","author":"Louis","year":"2001","journal-title":"Gut"},{"issue":"5","key":"10.1016\/bs.apha.2024.10.012_bib46","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/ecco-jcc\/jjy201","article-title":"Role of epithelial-to-mesenchymal transition in inflammatory bowel disease","volume":"13","author":"Lovisa","year":"2019","journal-title":"Journal of Crohn\u2019s and Colitis"},{"issue":"6","key":"10.1016\/bs.apha.2024.10.012_bib47","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1002\/ibd.21167","article-title":"Targeting TGF-beta1 by employing a vaccine ameliorates fibrosis in a mouse model of chronic colitis","volume":"16","author":"Ma","year":"2010","journal-title":"Inflammatory Bowel Diseases"},{"key":"10.1016\/bs.apha.2024.10.012_bib48","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.matbio.2017.11.010","article-title":"Inflammation and fibrosis","volume":"68-69","author":"Mack","year":"2018","journal-title":"Matrix Biology: Journal of the International Society for Matrix Biology"},{"issue":"6","key":"10.1016\/bs.apha.2024.10.012_bib49","doi-asserted-by":"crossref","first-page":"S188","DOI":"10.1016\/S0016-5085(20)31154-9","article-title":"A positive feedback loop between creeping fat (CF) and intestinal stricture formation in Crohn\u2019s disease: The role of CF-derived free fatty acids, extracellular matrix, and integrins","volume":"158","author":"Mao","year":"2020","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/bs.apha.2024.10.012_bib50","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/ibd\/izy331","article-title":"The mesenteric fat and intestinal muscle interface: Creeping fat influencing stricture formation in Crohn\u2019s disease","volume":"25","author":"Mao","year":"2019","journal-title":"Inflammatory Bowel Diseases"},{"issue":"6","key":"10.1016\/bs.apha.2024.10.012_bib51","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrneph.2016.48","article-title":"TGF-beta: The master regulator of fibrosis","volume":"12","author":"Meng","year":"2016","journal-title":"Nature Reviews Nephrology"},{"key":"10.1016\/bs.apha.2024.10.012_bib52","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2023.07.014","article-title":"Stricturing Crohn\u2019s disease single-cell RNA sequencing reveals fibroblast heterogeneity and intercellular interactions","author":"Mukherjee","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/bs.apha.2024.10.012_bib53","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3389\/fcvm.2020.00034","article-title":"Therapeutic targets for the treatment of cardiac fibrosis and cancer: Focusing on TGF-beta signaling","volume":"7","author":"Parichatikanond","year":"2020","journal-title":"Frontiers in Cardiovascular Medicine"},{"issue":"7","key":"10.1016\/bs.apha.2024.10.012_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0218971","article-title":"Cadherin-11 contributes to liver fibrosis induced by carbon tetrachloride","volume":"14","author":"Pedroza","year":"2019","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/bs.apha.2024.10.012_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187109","article-title":"Targeting of cadherin-11 decreases skin fibrosis in the tight skin-1 mouse model","volume":"12","author":"Pedroza","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/bs.apha.2024.10.012_bib56","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.matbio.2016.01.010","article-title":"Inflammation, fibrosis, and modulation of the process by mesenchymal stem\/stromal cells","volume":"51","author":"Prockop","year":"2016","journal-title":"Matrix Biology: Journal of the International Society for Matrix Biology"},{"issue":"3","key":"10.1016\/bs.apha.2024.10.012_bib57","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1148\/radiol.2523082167","article-title":"Mural inflammation in Crohn disease: Location-matched histologic validation of MR imaging features","volume":"252","author":"Punwani","year":"2009","journal-title":"Radiology"},{"key":"10.1016\/bs.apha.2024.10.012_bib58","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.cyto.2018.11.003","article-title":"Interleukin-17: Friend or foe in organ fibrosis","volume":"120","author":"Ramani","year":"2019","journal-title":"Cytokine"},{"issue":"7","key":"10.1016\/bs.apha.2024.10.012_bib59","doi-asserted-by":"crossref","DOI":"10.3390\/toxins15070473","article-title":"MiR-155-5p elevated by ochratoxin A induces intestinal fibrosis and epithelial-to-mesenchymal transition through TGF-beta regulated signaling pathway in vitro and in vivo","volume":"15","author":"Rhee","year":"2023","journal-title":"Toxins (Basel)"},{"issue":"2","key":"10.1016\/bs.apha.2024.10.012_bib60","article-title":"Reliability of MR enterography features for describing fibrostenosing Crohn disease","volume":"312","author":"Rieder","year":"2024","journal-title":"Radiology"},{"issue":"11-12","key":"10.1016\/bs.apha.2024.10.012_bib61","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1111\/apt.15032","article-title":"Editorial: Treating strictures in inflammatory bowel disease-authors\u2019 reply","volume":"48","author":"Rieder","year":"2018","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"4","key":"10.1016\/bs.apha.2024.10.012_bib62","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/MOG.0b013e3282ff8b36","article-title":"Intestinal fibrosis in inflammatory bowel disease: Progress in basic and clinical science","volume":"24","author":"Rieder","year":"2008","journal-title":"Current Opinion in Gastroenterology"},{"issue":"4","key":"10.1016\/bs.apha.2024.10.012_bib63","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/nrgastro.2009.31","article-title":"Intestinal fibrosis in IBD\u2014A dynamic, multifactorial process","volume":"6","author":"Rieder","year":"2009","journal-title":"Nature Reviews Gastroenterology & Hepatology"},{"issue":"2","key":"10.1016\/bs.apha.2024.10.012_bib64","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1053\/j.gastro.2016.09.047","article-title":"Mechanisms, management, and treatment of fibrosis in patients with inflammatory bowel diseases","volume":"152","author":"Rieder","year":"2017","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/bs.apha.2024.10.012_bib65","article-title":"Reliability of CT enterography for describing fibrostenosing Crohn disease","volume":"312","author":"Rieder","year":"2024","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/bs.apha.2024.10.012_bib66","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.yexmp.2015.03.033","article-title":"Intestinal organoids: A model of intestinal fibrosis for evaluating anti-fibrotic drugs","volume":"98","author":"Rodansky","year":"2015","journal-title":"Experimental and Molecular Pathology"},{"issue":"4","key":"10.1016\/bs.apha.2024.10.012_bib67","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1007\/s10620-013-2813-8","article-title":"Fibrocytes are involved in inflammation as well as fibrosis in the pathogenesis of Crohn\u2019s disease","volume":"59","author":"Sazuka","year":"2014","journal-title":"Digestive Diseases and Sciences"},{"issue":"4","key":"10.1016\/bs.apha.2024.10.012_bib68","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1053\/j.gastro.2018.11.029","article-title":"Inhibiting interleukin 36 receptor signaling reduces fibrosis in mice with chronic intestinal inflammation","volume":"156","author":"Scheibe","year":"2019","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/bs.apha.2024.10.012_bib69","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/ibd\/izac221","article-title":"Deletion of Smad7 ameliorates intestinal inflammation and contributes to fibrosis","volume":"29","author":"Schuler","year":"2023","journal-title":"Inflammatory Bowel Diseases"},{"issue":"6","key":"10.1016\/bs.apha.2024.10.012_bib70","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1038\/mi.2014.37","article-title":"Inhibition of a novel fibrogenic factor Tl1a reverses established colonic fibrosis","volume":"7","author":"Shih","year":"2014","journal-title":"Mucosal Immunology"},{"issue":"4","key":"10.1016\/bs.apha.2024.10.012_bib71","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s10620-013-2888-2","article-title":"Fibrocytes, inflammation, and fibrosis in Crohn\u2019s disease: Another piece of the puzzle","volume":"59","author":"Sorrentino","year":"2014","journal-title":"Digestive Diseases and Sciences"},{"issue":"3","key":"10.1016\/bs.apha.2024.10.012_bib72","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1148\/radiol.09091165","article-title":"Suspected anastomotic recurrence of Crohn disease after ileocolic resection: Evaluation with CT enteroclysis","volume":"254","author":"Soyer","year":"2010","journal-title":"Radiology"},{"issue":"28","key":"10.1016\/bs.apha.2024.10.012_bib73","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.3748\/wjg.v18.i28.3635","article-title":"Cellular and molecular mechanisms of intestinal fibrosis","volume":"18","author":"Speca","year":"2012","journal-title":"World Journal of Gastroenterology: WJG"},{"key":"10.1016\/bs.apha.2024.10.012_bib74","article-title":"Biomarkers for the prediction and diagnosis of fibrostenosing Crohn\u2019s disease: A systematic review","author":"Steiner","year":"2021","journal-title":"Clinical Gastroenterology and Hepatology: The Official Clinical Practice Journal of the American Gastroenterological Association"},{"issue":"3","key":"10.1016\/bs.apha.2024.10.012_bib75","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/ibd\/izaa169","article-title":"AXL is a potential target for the treatment of intestinal fibrosis","volume":"27","author":"Steiner","year":"2021","journal-title":"Inflammatory Bowel Diseases"},{"key":"10.1016\/bs.apha.2024.10.012_bib76","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3389\/fped.2017.00141","article-title":"Crohn\u2019s strictures-moving away from the knife","volume":"5","author":"Stenke","year":"2017","journal-title":"Frontiers in Pediatrics"},{"issue":"9","key":"10.1016\/bs.apha.2024.10.012_bib77","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1016\/j.ejrad.2011.07.013","article-title":"Non-perforating small bowel Crohn\u2019s disease assessed by MRI enterography: Derivation and histopathological validation of an MR-based activity index","volume":"81","author":"Steward","year":"2012","journal-title":"European Journal of Radiology"},{"issue":"4","key":"10.1016\/bs.apha.2024.10.012_bib78","first-page":"393","article-title":"Stromal and immune cells in gut fibrosis: The myofibroblast and the scarface","volume":"30","author":"Valatas","year":"2017","journal-title":"Annals of Gastroenterology"},{"issue":"3","key":"10.1016\/bs.apha.2024.10.012_bib79","doi-asserted-by":"crossref","first-page":"C671","DOI":"10.1152\/ajpcell.00307.2024","article-title":"Muscular hyperplasia in Crohn\u2019s disease strictures: through thick and thin","volume":"327","author":"Veisman","year":"2024","journal-title":"American Journal of Physiology. Cell Physiology"},{"issue":"6","key":"10.1016\/bs.apha.2024.10.012_bib80","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1093\/ecco-jcc\/jjx186","article-title":"Magnetic resonance imaging predicts histopathological composition of ileal Crohn\u2019s disease","volume":"12","author":"Wagner","year":"2018","journal-title":"Journal of Crohn\u2019s and Colitis"},{"issue":"1","key":"10.1016\/bs.apha.2024.10.012_bib81","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/imr.12974","article-title":"Novel mechanisms and clinical trial endpoints in intestinal fibrosis","volume":"302","author":"Wang","year":"2021","journal-title":"Immunological Reviews"},{"issue":"1","key":"10.1016\/bs.apha.2024.10.012_bib82","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/ecco-jcc\/jjx111","article-title":"Validity of contrast-enhanced ultrasonography and dynamic contrast-enhanced MR enterography in the assessment of transmural activity and fibrosis in Crohn\u2019s disease","volume":"12","author":"Wilkens","year":"2018","journal-title":"Journal of Crohn\u2019s and Colitis"},{"issue":"6","key":"10.1016\/bs.apha.2024.10.012_bib83","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/13543784.2023.2219386","article-title":"Promising phase II biologics for future Crohn\u2019s disease therapy","volume":"32","author":"Wils","year":"2023","journal-title":"Expert Opinion on Investigational Drugs"},{"issue":"5","key":"10.1016\/bs.apha.2024.10.012_bib84","doi-asserted-by":"crossref","first-page":"777","DOI":"10.14309\/ajg.0000000000000237","article-title":"Serum protein biomarkers of fibrosis aid in risk stratification of future stricturing complications in pediatric Crohn\u2019s disease","volume":"114","author":"Wu","year":"2019","journal-title":"The American Journal of Gastroenterology"},{"key":"10.1016\/bs.apha.2024.10.012_bib85","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.matbio.2023.08.001","article-title":"SIRT4 protects against intestinal fibrosis by facilitating GLS1 degradation","volume":"122","author":"Xue","year":"2023","journal-title":"Matrix Biology: Journal of the International Society for Matrix Biology"},{"key":"10.1016\/bs.apha.2024.10.012_bib86","doi-asserted-by":"crossref","DOI":"10.5217\/ir.2019.09148","article-title":"Fibrostenotic strictures in Crohn\u2019s disease","author":"Yoo","year":"2020","journal-title":"Intestinal Research"},{"key":"10.1016\/bs.apha.2024.10.012_bib87","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.3389\/fimmu.2019.02532","article-title":"Biology of IL-36 signaling and its role in systemic inflammatory diseases","volume":"10","author":"Yuan","year":"2019","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/bs.apha.2024.10.012_bib88","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3389\/fphar.2019.00162","article-title":"The molecular mechanism of transforming growth factor-beta signaling for intestinal fibrosis: A mini-review","volume":"10","author":"Yun","year":"2019","journal-title":"Frontiers in Pharmacology"},{"issue":"11","key":"10.1016\/bs.apha.2024.10.012_bib89","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1007\/s10620-018-5234-x","article-title":"IL-17A promotes initiation and development of intestinal fibrosis through EMT","volume":"63","author":"Zhang","year":"2018","journal-title":"Digestive Diseases and Sciences"},{"issue":"1","key":"10.1016\/bs.apha.2024.10.012_bib90","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1053\/j.gastro.2022.09.006","article-title":"Th17 cell-derived amphiregulin promotes colitis-associated intestinal fibrosis through activation of mTOR and MEK in intestinal myofibroblasts","volume":"164","author":"Zhao","year":"2023","journal-title":"Gastroenterology"}],"container-title":["Advances in Pharmacology","Emerging Therapeutic Targets and Drug Delivery Approaches in IBD"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054358924000413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054358924000413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T16:29:28Z","timestamp":1762360168000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1054358924000413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9780443313585"],"references-count":90,"URL":"https:\/\/doi.org\/10.1016\/bs.apha.2024.10.012","relation":{},"ISSN":["1054-3589"],"issn-type":[{"value":"1054-3589","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]}}}